blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1692128

EP1692128 - INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.10.2009
Database last updated on 12.07.2024
Most recent event   Tooltip09.10.2009Application deemed to be withdrawnpublished on 11.11.2009  [2009/46]
Applicant(s)For all designated states
Signal Pharmaceuticals LLC
4550 Towne Centre Court
San Diego, CA 92121 / US
[2006/34]
Inventor(s)01 / BHAGWAT, Shripad, S.
5015 Ashley Falls Court
San Diego, CA 92130 / US
02 / SATOH, Yoshitaka
11460 Larmier Circle
San Diego, CA 92131 / US
03 / SAKATA, Steven, T.
5290 Timber Branch Way
San Diego, CA 92130 / US
04 / BUHR, Chris, A.
355 Belmont Avenue
Redwood City, CA 94061 / US
05 / ALBERS, Ronald
6559 Comly Street
San Diego, CA 94111 / US
06 / SAPIENZA, John
1654 Ridge Rock Court
Chula Vista, CA 91913 / US
07 / PLANTEVIN, Veronique
11045 Alonda Court
San Diedo, CA 92126 / US
08 / CHAO, Qi
7696 Marker Road
San Diego, CA 92130 / US
09 / SAHASRABUDHE, Kiran
9820 Reagan Road, Apt. 210
San Diego, CA 92126 / US
10 / FERRY, Rachel
2011 Polk Avenue
San Diego, CA 92104 / US
11 / NARLA, Rama, K.
8246 Bryn Glen Way
San Diego, CA 92129 / US
 [2006/39]
Former [2006/34]01 / BHAGWAT, Shripad, S.
5015 Ashley Falls Court
San Diego, CA 92130 / US
02 / SATOH, Yoshitaka
11460 Larmier Circle
San Diego, CA 92131 / US
03 / SAKATA, Steven, T.
5290 Timber Branch Way
San Diego, CA 92130 / US
04 / BUHR, Chris, A.
355 Belmont Avenue
Redwood City, CA 94061 / US
05 / ALBERS, Ronald
6559 Comly Street
San Diego, CA 94111 / US
06 / SAPIENZA, John
1654 Ridge Rock Court
Chula Vista, CA 91913 / US
07 / PLANTEVIN, Veronique
11045 Alonda Court
San Diedo, CA 92126 / US
08 / CHAO, Qi
12604 Torrey Bluff Drive
San Diego, CA 92130 / US
09 / SAHASRABUDHE, Kiran
9820 Reagan Road, Apt. 210
San Diego, CA 92126 / US
10 / FERRY, Rachel
4385 Georgia Street, 6
San Diego, CA 92103 / US
11 / NARLA, Rama, K.
8246 Bryn Glen Way
San Diego, CA 92129 / US
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[N/P]
Former [2006/34]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München / DE
Application number, filing date04811774.119.11.2004
[2006/34]
WO2004US39113
Priority number, dateUS20030608929P19.11.2003         Original published format: US 608929 P
[2006/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005051942
Date:09.06.2005
Language:EN
[2005/23]
Type: A1 Application with search report 
No.:EP1692128
Date:23.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 09.06.2005 takes the place of the publication of the European patent application.
[2006/34]
Search report(s)International search report - published on:EP09.06.2005
ClassificationIPC:C07D403/04, C07D401/14, C07D403/14, C07D403/12, A61K31/416, A61K31/4196
[2006/34]
CPC:
C07D403/12 (EP,US); A61P1/04 (EP); A61P11/00 (EP);
A61P13/08 (EP); A61P13/12 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P9/08 (EP); A61P9/10 (EP); C07D401/14 (EP,US);
C07D403/04 (EP,US); C07D403/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/34]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:INDAZOLVERBINDUNGEN UND VERFAHREN ZU DEREN ANWENDUNG ALS PROTEINKINASEINHIBITOREN[2006/34]
English:INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS[2006/34]
French:COMPOSES D'INDAZOLE ET LEURS PROCEDES D'UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE KINASE[2006/34]
Entry into regional phase14.06.2006National basic fee paid 
14.06.2006Designation fee(s) paid 
14.06.2006Examination fee paid 
Examination procedure10.06.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.06.2006Examination requested  [2006/34]
03.08.2006Amendment by applicant (claims and/or description)
28.06.2007Despatch of a communication from the examining division (Time limit: M04)
02.11.2007Reply to a communication from the examining division
10.09.2008Date of oral proceedings
10.12.2008Minutes of oral proceedings despatched
12.12.2008Communication of intention to grant the patent
23.04.2009Application deemed to be withdrawn, date of legal effect  [2009/46]
02.06.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/46]
Divisional application(s)EP08015782.9   Application deemed to be withdrawn  : 09.10.2008
EP08022584.0  / EP2065383
Fees paidRenewal fee
14.11.2006Renewal fee patent year 03
15.11.2007Renewal fee patent year 04
27.11.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[PX]WO2004094388  (SIGNAL PHARM LLC [US], et al) [PX] 1-106 * claims 1,3,7-9,14,17,18,22,23,6-36,40-42,47,50,51; compounds 188,190,408,409 *;
 [Y]WO03004488  (CHIRON CORP [US], et al) [Y] 1-106 * claims 1-71 *;
 [XD]WO0210137  (SIGNAL PHARM INC [US], et al) [XD] 1-106 * claims 1-3,8,9,14,17,18,5-32,37,38,43,46,47,50-52; compounds 188,190,408,409 *;
 [Y]WO0102369  (AGOURON PHARMA [US]) [Y] 1-106 * claims 1-17 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.